Ramos-Hernández, Rafael
Busto, Natalia
Miguel-Ortega, Álvaro
Martínez-Ferrán, María
Santamaría-Peláez, Mirian
Saiz-Rodríguez, Miriam
Mielgo-Ayuso, Juan
Funding for this research was provided by:
Universidad de Burgos
Article History
Received: 15 October 2025
Accepted: 24 December 2025
First Online: 9 January 2026
Change Date: 21 March 2026
Change Type: Update
Change Details: In the sentence beginning ‘During each 6-week intervention phase,’ in this article, the text ‘received either 3 g/day of CRE combined with 3 g/day of HMB (free acid form)’ should have read ‘received either 3 g/day of CRE combined with 3 g/day of calcium HMB (HMB-Ca)’.
Change Date: 27 April 2026
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s40520-026-03377-5
Declarations
:
: The authors declare no competing interests.
: All procedures performed in this study were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. The study protocol was approved by the Ethics Committee of the University of Burgos (approval code: IR 24/2023) and registered at ClinicalTrials.gov (Identifier: NCT05951439). Written informed consent was obtained from all participants prior to enrollment.
: Generative AI was not used to create or alter figures or data. Language editing assistance (if any) was performed under human oversight; authors take full responsibility for the content.